BioSyent Q2 Results: Earnings release scheduled for August 13

0 min read     Updated on 14 Aug 2026, 03:18 AM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

BioSyent Inc. will report Q2 and H1 2026 earnings on August 13, 2026. CEO René Goehrum will present the results online. The specialty healthcare company focuses on pharmaceutical and oral health products in Canada and internationally.

powered bylight_fuzz_icon
48203326

*this image is generated using AI for illustrative purposes only.

BioSyent Inc. (TSXV: RX) will release its consolidated financial results for the three and six months ended June 30, 2026, after market hours on Thursday, August 13, 2026.

President and CEO René Goehrum will present the company’s second quarter and first half 2026 results on the date of release. The presentation will be available on BioSyent’s website.

Company Profile

Listed on the TSX Venture Exchange under the trading symbol "RX", BioSyent is a profitable growth-oriented specialty healthcare products company. The firm focuses on acquiring or in-licensing, marketing, and distributing innovative pharmaceutical and oral health products that have been successfully developed and have a proven track record of improving patient lives.

BioSyent supports healthcare professionals by marketing its products through its Pharmaceutical and Oral Health businesses in Canada and internationally.

As of the date of this press release, the company has 11,312,635 common shares outstanding.

How will BioSyent's Q2 2026 revenue growth compare to analyst expectations given its focus on acquired pharmaceutical assets?

What strategic acquisitions or in-licensing deals is BioSyent likely to pursue in the second half of 2026 to sustain its profitability?

How might fluctuations in the Canadian healthcare sector impact BioSyent's distribution margins for its oral health products in upcoming quarters?

like18
dislike

BioSyent CEO to present at Planet MicroCap Las Vegas

1 min read     Updated on 15 Jun 2026, 08:26 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

BioSyent Inc. will attend the Planet MicroCap Las Vegas investor conference from June 16 to 18, 2026. President and CEO René Goehrum will present on June 17 at 4:00pm PDT and meet with investors on June 17 and 18. The company has 11,331,974 common shares outstanding.

powered bylight_fuzz_icon
43080983

*this image is generated using AI for illustrative purposes only.

BioSyent Inc. will attend the Planet MicroCap Las Vegas investor conference at the Bellagio Hotel in Las Vegas, Nevada from June 16 to 18, 2026. The company aims to engage with investors and showcase its specialty healthcare products portfolio during the event.

Mr. René Goehrum, President and CEO of BioSyent, will present in person to attendees on Wednesday, June 17 at 4:00pm PDT. He will also conduct one-on-one meetings with registered attendees on June 17 and June 18, subject to availability through the conference organizers.

Listed on the TSX Venture Exchange under the symbol "RX", BioSyent focuses on acquiring or in-licensing, marketing, and distributing innovative pharmaceutical and oral health products. The company operates through its Pharmaceutical and Oral Health businesses in Canada and internationally.

As of the date of this press release, BioSyent has 11,331,974 common shares outstanding. The company is described as a profitable, growth-oriented entity supporting healthcare professionals with products that have a proven track record of improving patient lives.

Key Conference Details

Event Date Time Location
Conference Dates June 16–18, 2026 Bellagio Hotel, Las Vegas
CEO Presentation June 17, 2026 4:00pm PDT Bellagio Hotel
One-on-One Meetings June 17–18, 2026 By request Bellagio Hotel

What new product pipelines or acquisition targets does BioSyent plan to highlight during the conference?

How might the investor conference impact BioSyent's stock liquidity and trading volume on the TSX Venture Exchange?

What strategic partnerships or distribution agreements could emerge from the one-on-one meetings at the event?

like19
dislike
Must Read Next

Earnings

Latest Results: 130+ Indian companies report earnings today 34 mins ago
no imag found
Honasa Consumer Q1 net profit more than doubles YoY to 902M rupees 35 mins ago
DCW Q1 net profit triples YoY to ₹345M; revenue up to ₹5.4B 36 mins ago